Dr HERVE ABOU

📢New article on Our Stories!    👨‍💼 What does it mean to be a Pharmaceutical Sales Representative at Santen?  👩‍⚕️ How do they approach their work with patients and doctors?  💎 What makes Santen Sales Representatives unique in the pharmaceutical industry?    In this article, we spoke with Kenji Haruna, Pharmaceutical Sales Representative, who shares his personal journey, daily challenges, and the passion behind his work in ophthalmology. His story highlights how patient-centric thinking and teamwork drive continuous growth and build trust among healthcare professionals and colleagues.    Read the full story here 👉 https://lnkd.in/gEfWg9MG   #Ophthalmology #SalesRepresentative #CareerStories #PatientCentricity #JoinOurTeam #PharmaJobs 

88

1 commentaire

🚨 Global Safety, Local Expertise How do leading pharmaceutical companies manage complex safety operations across six continents? Fortrea’s latest case study reveals how its “One Safety” solution delivers end-to-end pharmacovigilance support—from clinical development to post-marketing surveillance. 📄https://lnkd.in/eY7V4pi8

137

France’s Early Access system provides a vital route for patients to access innovative therapies ahead of market authorisation, but navigating its complexities requires precision and strategy. Watch nathalie CAIZERGUES, Medical Affairs Director, Europe, at the Clinigen Insights Virtual Week, as she breaks down: • Core requirements of France’s Early Access framework • How to handle exceptions and edge cases with confidence • Proven strategies for smooth and compliant implementation Watch the full session here https://lnkd.in/et6Gg6bP #EarlyAccess #MarketAccess #RegulatoryAffairs #ClinigenInsights #MAP #Pharma #HTA #France

41

➡️ Tech transfer can make or break your drug’s success. Selecting the right CDMO isn’t just about capabilities; it’s about how seamlessly they can bring your process online. From regulatory strength and scientific expertise to capacity and culture, every detail matters. In this article, we break down 5 key factors for successful tech transfer and how a partner like Bora, with a customer-first mindset and global GMP footprint, can set your program up for speed and success. 📙Read the article: https://bit.ly/4oVlqhw #TechTransfer #CDMO #PharmaManufacturing #PharmaceuticalDevelopment #QualityMatters

49

We’re working with Johnson & Johnson Innovative Medicine to develop new therapies for patients at risk of blood clots — aiming to reduce the risk of potential bleeding and thrombotic events. Atrial fibrillation advocate Mellanie True Hills, CSP shares how patient perspectives drive innovation and shape better care. Discover how science and partnership are helping us reimagine cardiovascular treatment: https://bit.ly/46EpMkV #WorldHeartDay

127

3 commentaires